Hitachi Announces Changes in the Method of the Reorganization of Hitachi Medical and Hitachi Aloka Medical and the Execution of Absorption-type Company Split Agreement

Tokyo, January 13, 2016 --- Hitachi, Ltd. (TSE:6501, “Hitachi”), Hitachi Medical Corporation (“Hitachi Medical”), and Hitachi Aloka Medical, Ltd. (“Hitachi Aloka Medical”) announced on July 21, 2015, that a decision had been made regarding the absorption-type merger of Hitachi Medical and Hitachi Aloka Medical by Hitachi, and the establishment of a manufacturing subsidiary, as part of efforts to strengthen the healthcare business. After that, as a result of further consideration on the optimum business operation structure, etc., they today agreed to transfer non-manufacturing divisions (e.g., sales and planning divisions; the “Divisions to Be Transferred”) from Hitachi Medical and Hitachi Aloka Medical to Hitachi through an absorption-type company split (the “Company Split) and to conduct an absorption-type merger of Hitachi Aloka Medical by Hitachi Medical after the Company Split. They also today executed an absorption-type company split agreement (the “Absorption-type Company Split Agreement”).